|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/113 | |
| A61K 31/712 | |||
| A61K 31/7125 | |||
| A61K 31/7115 |
| (11) | Patento numeris | 3310918 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16742444.9 |
| Europos patento paraiškos padavimo data | 2016-06-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-04-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-08-05 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/037563 |
| Data | 2016-06-15 |
| (87) | Numeris | WO 2016/205323 |
| Data | 2016-12-22 |
| (30) | Numeris | Data | Šalis |
| 201562181602 P | 2015-06-18 | US |
| (72) |
HINKLE, Gregory, US
|
| (73) |
Alnylam Pharmaceuticals, Inc.,
300 Third Street, 3rd Floor, Cambridge, MA 02142,
US
|
| (54) | POLYNUCLEOTIDE AGENTS TARGETING HYDROXYACID OXIDASE (GLYCOLATE OXIDASE, HAO1) AND METHODS OF USE THEREOF |
| POLYNUCLEOTIDE AGENTS TARGETING HYDROXYACID OXIDASE (GLYCOLATE OXIDASE, HAO1) AND METHODS OF USE THEREOF |